Barts Endocarditis Registry

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational registry enrolling patients aged 16 and over with confirmed or suspected infective endocarditis, including device-related cases, who are treated or followed at Barts Heart Centre. Clinical, demographic, microbiological, imaging, surgical, and outcome data will be recorded and stored to define the local patient cohort. The registry is intended to track guideline implementation, document diagnostic and treatment patterns, and provide a baseline for future genomic and interventional trials. Data collection will support quality improvement and enable planned downstream research projects.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* • Patients aged 16 and over (Patients under 16 years of age are not admitted to Barts Heart Centre)

  * Patients admitted to Barts Heart Centre with confirmed Endocarditis (see above)
  * Patients attending outpatients with confirmed/suspected Endocarditis
  * Patients with possible IE who complete treatment for endocarditis
  * Patients with cardiac device related Endocarditis
  * Patients with the ability to provide informed consent

Exclusion Criteria:

* • Patients with pacemaker pocket infection with no evidence of pacemaker lead or valve infection

  * Patients who refuse consent to be included in the research database
  * Patients with "rejected" endocarditis

Where it's running

• St Bartholomews Hospital
  London, United Kingdom Recruiting

Study contacts

• Principal investigator: Simon Woldman, MSc — St Bartholomews Hospital
• Study coordinator: Innocent Bvekerwa, MSc
• Email: i.bvekerwa@nhs.net
• Phone: 07852209005

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Al[18F]F-NOTA-folate PET imaging in suspected cardiac sarcoidosis and infective endocarditis

  This diagnostic test uses a folate-based PET tracer to see if it can help identify inflammation or infection in the heart for people with suspected cardiac sarcoidosis or infective endocarditis.

  Recruiting Turku University Hospital · Turku · NCT07814222

• Etiologic Diagnosis Algorithm in Infective Endocarditis

  Aiming to see if a combined culture and molecular testing approach can help doctors choose the right antibiotics faster for adults with infective endocarditis.

  Recruiting at 2 sites I.M. Sechenov First Moscow State Medical University · Moscow and 2 other locations · NCT07682389

• Rifampin-free therapy vs rifampin-containing therapy for staphylococcal prosthetic valve endocarditis

  This study tests whether a rifampin-free antibiotic regimen can be as effective as a rifampin-containing regimen for adults with staphylococcal prosthetic valve endocarditis.

  Recruiting at 29 sites Phase 3 Nantes University Hospital · Aix-les-Bains and 30 other locations · NCT07345325

• Using bacteriophages with antibiotics to treat infective endocarditis

  This study is testing whether using a special virus called bacteriophages along with antibiotics can help people with a serious heart infection called infective endocarditis.

  Recruiting Phase 3 University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) · Moscow · NCT06870409

• Improving health and quality of life for patients recovering from infective endocarditis through cardiac rehabilitation

  This study is testing if joining a cardiac rehabilitation program can help people recovering from infective endocarditis feel healthier and improve their quality of life.

  Recruiting Region Halland · Halmstad, Halland County · NCT06704048

• Echocardiography versus no echocardiography for Staphylococcus aureus bloodstream infection with VIRSTA score <3

  This trial tests whether it is safe to skip routine echocardiography in adults hospitalized with Staphylococcus aureus bloodstream infection who have a VIRSTA score under 3.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06457386

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.